drugset / Trial / NCT03451487
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study
RandomizedParallel-groupSingle-blindOther
Summary
To investigate and compare the possible response of Panadol® and SafeTynadol® formulations in healthy volunteers.
Timeline
- Start
- 2022-05-19
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 1000 mg | Oral |
| Comparator | Acetaminophen | Small molecule | 4000 mg | Oral |
| Subject | SafeTynadol | Unknown | 1000 mg | Oral |
| Subject | SafeTynadol | Unknown | 4000 mg | Oral |